SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-21-021553
Filing Date
2021-02-12
Accepted
2021-02-12 12:05:17
Documents
25

Document Format Files

Seq Description Document Type Size
1 424B3 tm211883-6_424b3.htm 424B3 7065449
2 GRAPHIC lg_anchiano-4c.jpg GRAPHIC 33160
3 GRAPHIC sg_stanislavpolo-bw.jpg GRAPHIC 21348
4 GRAPHIC tm211883d1-bc_pipeline4clr.jpg GRAPHIC 99438
5 GRAPHIC tm211883d1-fc_role4clr.jpg GRAPHIC 127065
6 GRAPHIC tm211883d1-tbl_target4clr.jpg GRAPHIC 167711
7 GRAPHIC tm211883d1-tbl_solution4clr.jpg GRAPHIC 140755
8 GRAPHIC tm211883d1-pht_levels4clr.jpg GRAPHIC 117284
9 GRAPHIC tm211883d1-pht_biopsies4clr.jpg GRAPHIC 73111
10 GRAPHIC tm211883d1-lc_patient4cbw.jpg GRAPHIC 73368
11 GRAPHIC tm211883d1-bc_circulat4clr.jpg GRAPHIC 42262
12 GRAPHIC tm211883d1-pht_tissue4clr.jpg GRAPHIC 142046
13 GRAPHIC tm211883d1-pht_skintise4clr.jpg GRAPHIC 138896
14 GRAPHIC tm211883d1-lc_fibrotic4cbw.jpg GRAPHIC 32349
15 GRAPHIC tm211883d1-bc_fiveadmin4clr.jpg GRAPHIC 44167
16 GRAPHIC tm211883d1-bc_nineadmin4clr.jpg GRAPHIC 55267
17 GRAPHIC tm211883d1-bc_eightadmn4clr.jpg GRAPHIC 49317
18 GRAPHIC tm211883d1-lc_activaton4cbw.jpg GRAPHIC 23761
19 GRAPHIC tm211883d1-pht_fibrosis4clr.jpg GRAPHIC 79690
20 GRAPHIC tm211883d1-bc_monocytes4cbw.jpg GRAPHIC 41247
21 GRAPHIC tm211883d1-pht_healthy4clr.jpg GRAPHIC 107032
22 GRAPHIC tm211883d1-pht_dermal4clr.jpg GRAPHIC 129275
23 GRAPHIC tm211883d1-pht_inhibits4clr.jpg GRAPHIC 172789
24 GRAPHIC lg_oppenheimer.jpg GRAPHIC 15604
25 GRAPHIC sg_oppenheimer-lr.jpg GRAPHIC 15343
  Complete submission text file 0001104659-21-021553.txt   9738786
Mailing Address 5 KIRYAT HAMADA ST PO BOX 45032 JERUSALEM L3 9777401
Business Address 5 KIRYAT HAMADA ST PO BOX 45032 JERUSALEM L3 9777401 972-2-5486555
Anchiano Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-252070 | Film No.: 21624655
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences